Women who received hormone replacement therapy for six months after a hip or knee replacement surgery had a 38% lower risk of repeat surgery over three years of follow-up than those who did not get hormone treatments, according to a study in the journal Annals of the Rheumatic Diseases. The risk of a second joint replacement surgery decreased further with a year of usage, researchers reported. The absolute risk of needing a second surgery was small, and providers should weigh the risks and benefits of hormone therapy, researchers said.

Full Story:
HealthDay News

Related Summaries